Truly Translational Sweden AB is a company based in Lund that operates as a full-service strategic partner in drug development. The organization specializes in preclinical and early clinical drug development, providing a range of services designed to support pharmaceutical and biotechnology companies. Their offerings include business consultancy services and access to both in vitro and in vivo studies, which are essential for the development of new therapeutic agents.
The company places a strong emphasis on precision medicine, aiming to tailor drug development strategies to meet specific patient needs. They provide strategic advice to clients, leveraging advanced technologies and services to enhance the drug development process. With expertise in preclinical pharmacology, Truly Translational Sweden AB is equipped to address various challenges in drug development, offering customized solutions that align with the unique requirements of each project.